(Q34969837)

5 August 2017

Effect of single-dose rifampin on the pharmacokinetics of warfarin in healthy volunteers (English)

1 reference

5 August 2017

1 reference

1 reference

1 reference

A Frymoyer

1

1 reference

5 August 2017

S Shugarts

2

1 reference

5 August 2017

M Browne

3

1 reference

5 August 2017

A H B Wu

4

1 reference

5 August 2017

L Frassetto

5

1 reference

5 August 2017

L Z Benet

6

1 reference

5 August 2017

language of work or name

English

0 references

publication date

11 August 2010

1 reference

Clinical Pharmacology & Therapeutics

5 August 2017

1 reference

5 August 2017

88

1 reference

5 August 2017

540-547

1 reference

5 August 2017

4

1 reference

https://scigraph.springernature.com/pub.10.1038/clpt.2010.142

5 August 2017

0 references

cites work

The role of transporters in the pharmacokinetics of orally administered drugs

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3091944

A genome-wide association study confirms VKORC1, CYP2C9, and CYP4F2 as principal genetic determinants of warfarin dose

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3091944

Elucidating rifampin's inducing and inhibiting effects on glyburide pharmacokinetics and blood glucose in healthy volunteers: unmasking the differential effects of enzyme induction and transporter inhibition for a drug and its primary metabolite

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3091944

Dosing algorithms to predict warfarin maintenance dose in Caucasians and African Americans

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3091944

The largest prospective warfarin-treated cohort supports genetic forecasting

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3091944

A genome-wide scan for common genetic variants with a large influence on warfarin maintenance dose

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3091944

Pharmacodynamic interaction of warfarin with cranberry but not with garlic in healthy subjects

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3091944

Pharmacogenetics of OATP (SLC21/SLCO), OAT and OCT (SLC22) and PEPT (SLC15) transporters in the intestine, liver and kidney

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3091944

Use of pharmacogenetic and clinical factors to predict the therapeutic dose of warfarin

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3091944

CYP4F2 genetic variant alters required warfarin dose

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3091944

Role of OATP transporters in the disposition of drugs

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3091944

Bosentan is a substrate of human OATP1B1 and OATP1B3: inhibition of hepatic uptake as the common mechanism of its interactions with cyclosporin A, rifampicin, and sildenafil

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3091944

effect of OATP1B transporter inhibition on the pharmacokinetics of atorvastatin in healthy volunteers

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3091944

Association of warfarin dose with genes involved in its action and metabolism

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3091944

Development of a fluorescence-based assay for screening of modulators of human organic anion transporter 1B3 (OATP1B3).

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3091944

Effect of ginkgo and ginger on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3091944

Predicting drug disposition via application of BCS: transport/absorption/ elimination interplay and development of a biopharmaceutics drug disposition classification system

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3091944

The pharmacology and management of the vitamin K antagonists: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3091944

Effect of St John's wort and ginseng on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3091944

Rifampicin seems to act as both an inducer and an inhibitor of the metabolism of repaglinide

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3091944

Effect of rifampicin on pravastatin pharmacokinetics in healthy subjects

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3091944

Pharmacokinetic interactions with rifampicin : clinical relevance

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3091944

Rifampin and rifabutin drug interactions: an update

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3091944

The effect of single does of rifampicin on the pharmacokinetics of oral nifedipine.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3091944

Human P450 metabolism of warfarin

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3091944

Dosing algorithm for warfarin using CYP2C9 and VKORC1 genotyping from a multi-ethnic population: comparison with other equations

8 July 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.142

Interactions of rifamycin SV and rifampicin with organic anion uptake systems of human liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.142

Cytochrome P450 induction by rifampicin in healthy subjects: determination using the Karolinska cocktail and the endogenous CYP3A4 marker 4beta-hydroxycholesterol

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.142

The area under the plasma concentration-time curve for oral midazolam is 400-fold larger during treatment with itraconazole than with rifampicin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.142

Ciprofloxacin prolonged-release tablets do not affect warfarin pharmacokinetics and pharmacodynamics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.142

In vitro and in vivo correlation of hepatic transporter effects on erythromycin metabolism: characterizing the importance of transporter-enzyme interplay

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.142

Effects of oral vitamin K on S- and R-warfarin pharmacokinetics and pharmacodynamics: enhanced safety of warfarin as a CYP2C9 probe

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.142

Effects of daily ingestion of cranberry juice on the pharmacokinetics of warfarin, tizanidine, and midazolam--probes of CYP2C9, CYP1A2, and CYP3A4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.142

Effect of exenatide on the pharmacokinetics and pharmacodynamics of warfarin in healthy Asian men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.142

The effect of CYP2C19 genotypes on the pharmacokinetics of warfarin enantiomers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.142

Pharmacokinetics of oral and intravenous rifampicin during chronic administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.142

Development and validation of a sensitive and robust LC-tandem MS method for the analysis of warfarin enantiomers in human plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.142

Pharmacokinetics of antituberculosis drugs in patients

21 January 2018

1 reference

12 December 2020

Losartan does not affect the pharmacokinetics and pharmacodynamics of warfarin

1 reference

12 December 2020

Differential induction of prehepatic and hepatic metabolism of verapamil by rifampin

1 reference

12 December 2020

The mechanism of the warfarin-rifampin drug interaction in humans

1 reference

12 December 2020

Identifiers

DOI

10.1038/CLPT.2010.142

1 reference

Dimensions Publication ID

5 August 2017

0 references

1 reference

5 August 2017

1 reference